Department of Colon and Rectal Surgery, University of Ulsan College of Medicine and Asan Medical Center, Asanbyeongwon-gil 86, Songpa-gu, Seoul, 138-736, Republic of Korea,
Int J Colorectal Dis. 2013 Dec;28(12):1667-74. doi: 10.1007/s00384-013-1761-2. Epub 2013 Aug 14.
To identify the indication and prognostic significance of lateral lymph node (LLN) excision in locally advanced rectal cancer patients underwent preoperative chemoradiotherapy.
Included were 67 consecutive patients with suspicious LLN metastasis who underwent chemoradiotherapy and surgery including selective LLN excision (82 excisions). The excisions were grouped according to the presence of LLN metastasis and compared in terms of the clinicopathological findings and oncological results. The correlation between the largest short-axis diameter of LLN measured by imaging and metastasis rates was explored.
LLN metastases were identified in 32 excisions (40.0 %). The calculated short-axis LLN diameter predicting metastasis was 11.7 mm (before chemoradiotherapy) and 11.4 mm (before surgery). LLN metastasis was observed more frequently in the low rectum (p = 0.031) and associated with higher CEA levels (p = 0.048). The 3-year overall survival rates for patients with and without LLN metastasis were 60.3 % and 90.3 % (p = 0.048), while the 3-year disease-free survival rates were 31.4 % and 70.5 % (p = 0.009). The hazard ratio of LLN metastasis for recurrence was 2.938 (95 % CI = 1.258-6.863).
LLN metastasis in rectal cancer patients underwent chemoradiotherapy was a distinct poor prognostic factor. Selective LLN excision based on imaging studies may have a role for such patients.
确定接受术前放化疗的局部进展期直肠癌患者行侧方淋巴结(LLN)切除的适应证和预后意义。
纳入 67 例经放化疗且接受选择性 LLN 切除(82 例切除)手术的可疑 LLN 转移患者。根据 LLN 是否转移将切除标本分组,并比较其临床病理特征和肿瘤学结果。探讨影像学测量的 LLN 最大短轴直径与转移率的相关性。
32 例(40.0%)切除标本中发现 LLN 转移。预测转移的 LLN 短轴直径(放化疗前)为 11.7mm,(术前)为 11.4mm。LLN 转移更常见于低位直肠(p=0.031),且与更高的 CEA 水平相关(p=0.048)。有和无 LLN 转移的患者 3 年总生存率分别为 60.3%和 90.3%(p=0.048),3 年无病生存率分别为 31.4%和 70.5%(p=0.009)。LLN 转移对复发的风险比为 2.938(95%CI=1.258-6.863)。
接受放化疗的直肠癌患者的 LLN 转移是一个明显的不良预后因素。基于影像学研究的选择性 LLN 切除可能对这类患者有作用。